Detection and genotyping of human papilloma virus in cervical cancer specimens from Saudi patients

International Journal of Gynecological Cancer

Volumn 21, Issue 5, 2011, Pages 907-910

  Al Badawi, Ismail A ^a   Al Suwaine, Abdulrahman ^a   Al Aker, Murad ^a   Asaad, Lina ^a   Alaidan, Alwaleed ^a   Tulbah, Asma ^a   Bohol, Marie Fe ^a   Munkarah, Adnan R ^b  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Cervical cancer; Detection methods; Genotypes; HPV; Saudi population

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER PATIENT; DISEASE ASSOCIATION; DNA SEQUENCE; DOT HYBRIDIZATION; FEMALE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SAUDI ARABIA; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; VIRUS ISOLATION; WART VIRUS;

EID: 82955196851     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e318214219f     Document Type: Article

References (20)

1. Walboomers JM, Jacobs MV, Manos MM, et al. Human papilloma virus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12-19. (Pubitemid 29406813)
2. Ho GY, Bierman R, Beardesley L, et al. Natural history of cervicovaginal papilloma virus infection in young women. N Engl J Med. 1998;338:423-428. (Pubitemid 28135669)
3. Bosch FX, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55:244-265. (Pubitemid 34293391)
4. Heard I. Ano-genital lesions due to human papilloma virus infection in women. Med Mal Infect. 2005;35:302-305. (Pubitemid 40725143)
5. Reithmuller D. Ano-genital papilloma viruses infections in women. Rev Pract. 2006;56:1893-1900.
6. Psyrri A, Dimaio D. Human papilloma viruses in cervical and head-and-neck cancer. Nat Clin Pract Oncol. 2008;5:25-31.
7. Munoz N, Bosch FX, Castellagué X, et al. Against which human papilloma virus types shall we vaccinate and screen? The international perspective. Int J Cancer. 2004;111:278-285. (Pubitemid 38924707)
8. World Health Organization (February 2006). "Fact Sheet No. 297: Cancer". Available at: Http:// www.who.int/mediacentre/factsheets/fs297/en/ index.html. Retrieved 2007-12-01. Accessed January 6, 2010.
9. Saudi Cancer Registry, Cancer Incidence Report Saudi Arabia 2005. Available at: Http://www.scr.org.sa/reports/SCR2005.pdf.
10. Sait KH. Attitudes, knowledge, and practices in relation to cervical cancer and its screening among women in Saudi Arabia. Saudi Med J. 2009;30:1208-1212.
11. Al-Muammar T, Al-Ahdal MN, Hassan A, et al. Human papilloma virus-16/18 cervical infection among women attending a family medical clinic in Riyadh. Ann Saudi Med. 2007;27:1-5. (Pubitemid 46579111)
12. Gravitt PE, Peyton CL, Apple RJ, et al. Genotyping of 27 human papilloma virus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol. 1998;36:3020-3027. (Pubitemid 28429431)
13. Jacobs MV, Snijders PJF, van den Bruie AJC, et al. A general primer GP5+/6+-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papilloma virus genotypes in cervical scrapings. J Clin Microbiol. 1997;35:791-795. (Pubitemid 27083888)
14. Meissner JD. Nucleotide sequences and further characterization of human papilloma virus DNA present in the CaSki, SiHa and HeLa cervical carcinoma cell lines. J Gen Virol. 1999;80:1725-1733. (Pubitemid 29319864)
15. Fontaine V, Mascaux C, Weyn C, et al. Evaluation of combined general primer-mediated PCR sequencing and type-specific PCR strategies for determination of human papilloma virus genotypes in cervical cell specimens. J Clin Microbiol. 2007;45:928-934. (Pubitemid 46427713)
16. van den Brule AJ, Pol R, Fransen-Daalmeijer N, et al. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high throughput identification of human papilloma virus genotypes. J ClinMicrobiol. 2002;40:779-787. (Pubitemid 34208623)
17. Zehbe I, Wilander E. Human papilloma virus infection and invasive cervical neoplasia: A study of prevalence and morphology. J Pathol. 1997;181:270-275. (Pubitemid 27156838)
18. Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papilloma virus in cervical cancer: A worldwide perspective. J Natl Cancer Inst. 1995;87:796-802.
19. Bosch FX, Burchell AN, Schiffman M, et al. Epidemiology and natural history of human papilloma virus infections and type-specific implications in cervical neoplasia. Vaccine. 2008;26(suppl 10):K1-K16.
20. Rousseau MC, Abrahamowicz M, Villa LL, et al. Predictors of cervical co-infection with multiple human papilloma virus types. Cancer Epidemiol Biomarkers Prev. 2003;12:1029-1037. (Pubitemid 37310259)